erythromycin has been researched along with Fetal Membranes, Premature Rupture in 51 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (3.92) | 18.7374 |
1990's | 13 (25.49) | 18.2507 |
2000's | 15 (29.41) | 29.6817 |
2010's | 16 (31.37) | 24.3611 |
2020's | 5 (9.80) | 2.80 |
Authors | Studies |
---|---|
Kopkin, RH; Seaman, RD; Turrentine, MA | 1 |
Kong, CW; Li, YY; To, WWK | 1 |
Martingano, D; Mitrofanova, A; Singh, S | 1 |
Broderick, D; Clooney, L; Drew, RJ; Eogan, M; Fitzgibbon, A; McCallion, N | 1 |
Bennett, PR; Brown, RG; MacIntyre, DA | 1 |
Dotters-Katz, S | 1 |
Appiagyei, A; Finneran, MM; Mertz, H; Templin, M | 1 |
Bennett, PR; Brown, RG; Holmes, E; Kindinger, LM; Lee, YS; Lehne, B; MacIntyre, DA; Marchesi, JR; Nicholson, JK; Smith, A; Terzidou, V | 1 |
Buhimschi, CS; Finneran, MM; Smith, DD | 1 |
Cazanave, C; Charlier, C; Doret Dion, M | 1 |
Bachilova, S; Berghella, V; Heidari, P; Hoffman, MK; Navathe, R; Roman, A; Schoen, CN; Smith, S; Tepper, J; Visintainer, P; Ward, A | 1 |
Cha, HH; Choi, SJ; Kim, JH; Kim, JS; Kwak, HM; Lee, JH; Oh, SY; Roh, CR; Shin, MY | 1 |
Leung, TY; Sahota, DS; Yeung, SW | 1 |
Gordon, SS; Haas, DM; Pierson, RC | 1 |
Ahmed, MR; Elnahas, KM; Hamdy, MA; Kamel, Z; Mohamed, ML; Sayed Ahmed, WA | 1 |
Chang, KH; Choi, SJ; Kim, HJ; Kim, JH; Kim, JS; Lee, J; Oh, SY; Roh, CR; Yu, HJ | 1 |
Brocklehurst, P; Jones, DR; Kenyon, S; Marlow, N; Pike, K; Salt, A; Taylor, DJ | 1 |
Russell, AR; Steer, PJ | 1 |
Brocklehurst, P; Jones, D; Kenyon, S; Marlow, N; Pike, K; Salt, A; Taylor, D | 1 |
Dixon-Woods, M; Jackson, CJ; Jones, DR; Kenyon, S; Tarrant, C | 1 |
Gámez Guevara, C; Hernández y Ballinas, A; López Farán, JA | 1 |
Crouse, DT; Dombrowski, MP; Goldenberg, RL; Mapp, DC; Meis, PJ; Mercer, BM; Miodovnik, M | 1 |
Bower, E; Brocklehurst, P; Jones, D; Kenyon, S; Kurinczuk, JJ; Marlow, N; Pike, K; Salt, A; Taylor, D | 1 |
Kenyon, S; Tarnow-Mordi, WO; Taylor, DJ | 1 |
Kenyon, S; Taylor, DJ | 1 |
Das, B; Mittal, A; Rastogi, S; Salhan, S | 1 |
Holliman, R; Russell, AR; Tan, S | 1 |
Bendon, RW; Das, AF; Goldenberg, RL; Mercer, BM; Miodovnik, M; Rabello, YA; Ramsey, RD; Thurnau, GR | 1 |
Arora, V; Luckas, MJ | 1 |
Brocklehurst, P; Jones, D; Kenyon, S; Marlow, N; Salt, A; Taylor, D | 1 |
Chung, JH; Clock, CA; Ehsanipoor, RM; McNulty, JA; Wing, DA | 1 |
Bieniarz, A; Gauthier, DW; Meyer, WJ | 1 |
Groome, LJ; Hauth, JC; Owen, J | 1 |
Biesterfeld, S; Heindrichs, U; Marquet, KL; Rath, W; Winkler, M | 1 |
Bottoms, SF; Das, AF; Goldenberg, RL; Iams, JD; McNellis, D; Meis, PJ; Mercer, BM; Merenstein, G; Miodovnik, M; Moawad, AH; Paul, RH; Rabello, YA; Ramsey, RD; Roberts, JM; Thom, EA; Thurnau, GR; Van Dorsten, JP | 1 |
French, L; Granados, MA | 1 |
Faxelius, G; Jónsson, B; Rylander, M | 1 |
Doria, V; Ghidini, A; Kirn, V; Korker, V | 1 |
Bar, J; Ben Rafael, Z; Hod, M; Maayan-Metsger, A; Orvieto, R; Shalev, Y; Sirota, L | 1 |
Kenyon, SL; Tarnow-Mordi, W; Taylor, DJ | 1 |
Epling, J; Grier, M; Patil, A; Weston, J; Xu, Y | 1 |
Willan, AR | 1 |
Buitendijk, SE | 1 |
Finci-Yeheskel, Z; Mayer, M; Milwidsky, A | 1 |
Hagay, Z; Mazor, M; Nores, J; Romero, R; Sepulveda, W | 1 |
Mercer, BM; Moretti, ML; Prevost, RR; Sibai, BM | 1 |
French, JI; McGregor, JA; Seo, K | 1 |
Lawellin, DW; Lunt, BD; McGregor, JA; Schoonmaker, JN | 1 |
Bachus, V; French, JI; Hillier, S; Judson, FN; McFee, J; McGregor, JA; Richter, R; Schoonmaker, J; Seo, K; Vuchetich, M | 1 |
Theunissen, I; van Lierde, M | 1 |
Baumann, L; Ruckhäberle, KE; Schiller, EM; Winkler, M | 1 |
5 review(s) available for erythromycin and Fetal Membranes, Premature Rupture
Article | Year |
---|---|
Erythromycin vs azithromycin for treatment of preterm prelabor rupture of membranes: a systematic review and meta-analysis.
Topics: Azithromycin; Chorioamnionitis; Erythromycin; Female; Fetal Membranes, Premature Rupture; Humans; Infant, Newborn; Pregnancy | 2022 |
Vaginal Microbiome in Preterm Rupture of Membranes.
Topics: Anti-Bacterial Agents; Chorioamnionitis; Dysbiosis; Erythromycin; Female; Fetal Membranes, Premature Rupture; Gestational Age; Humans; Infant, Newborn; Lactobacillus; Microbiota; Neonatal Sepsis; Pregnancy; Premature Birth; Risk Factors; Vagina | 2020 |
Antibiotics for Prophylaxis in the Setting of Preterm Prelabor Rupture of Membranes.
Topics: Ampicillin; Anti-Bacterial Agents; Antibiotic Prophylaxis; Azithromycin; Drug Administration Routes; Drug Therapy, Combination; Erythromycin; Female; Fetal Membranes, Premature Rupture; Gestational Age; Humans; Infant, Newborn; Pregnancy; Pregnancy Complications, Infectious | 2020 |
What we have learned regarding antibiotic therapy for the reduction of infant morbidity after preterm premature rupture of the membranes.
Topics: Amoxicillin; Ampicillin; Anti-Infective Agents; Drug Therapy, Combination; Erythromycin; Female; Fetal Membranes, Premature Rupture; Gestational Age; Humans; Infant Mortality; Infant, Newborn; Multicenter Studies as Topic; National Institutes of Health (U.S.); Pregnancy; Randomized Controlled Trials as Topic; Treatment Outcome; United States | 2003 |
[Erythromycin for premature rupture of membranes is beneficial for infant].
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Drug Therapy, Combination; Enterocolitis, Necrotizing; Erythromycin; Female; Fetal Membranes, Premature Rupture; Humans; Infant, Newborn; Obstetric Labor, Premature; Pregnancy; Pregnancy Outcome; Randomized Controlled Trials as Topic | 2001 |
13 trial(s) available for erythromycin and Fetal Membranes, Premature Rupture
Article | Year |
---|---|
Cost Analysis of Azithromycin versus Erythromycin in Pregnancies Complicated by Preterm Premature Rupture of Membranes.
Topics: Adult; Anti-Bacterial Agents; Antibiotic Prophylaxis; Azithromycin; Cost-Benefit Analysis; Erythromycin; Female; Fetal Membranes, Premature Rupture; Humans; Infant, Newborn; Male; Pregnancy; Pregnancy Outcome | 2019 |
The efficacy of cefazolin plus macrolide (erythromycin or clarithromycin) versus cefazolin alone in neonatal morbidity and placental inflammation for women with preterm premature rupture of membranes.
Topics: Adult; Anti-Bacterial Agents; Cefazolin; Chorioamnionitis; Clarithromycin; Echoencephalography; Erythromycin; Female; Fetal Membranes, Premature Rupture; Humans; Infant; Infant, Newborn; Nervous System Diseases; Pregnancy | 2013 |
[Comparison of maternal and perinatal outcomes in the conservative treatment preterm premature membrane rupture between the use of erythromycin and clindamycin].
Topics: Adult; Anti-Bacterial Agents; Antibiotic Prophylaxis; Chorioamnionitis; Clindamycin; Endometritis; Enterocolitis, Necrotizing; Erythromycin; Female; Fetal Membranes, Premature Rupture; Humans; Infant, Newborn; Infant, Premature, Diseases; Obstetric Labor, Premature; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Prospective Studies; Respiratory Distress Syndrome, Newborn; Risk Factors; Sepsis; Urinary Tract Infections; Uterine Cervicitis; Young Adult | 2011 |
ORACLE--antibiotics for preterm prelabour rupture of the membranes: short-term and long-term outcomes.
Topics: Adult; Amoxicillin-Potassium Clavulanate Combination; Antibiotic Prophylaxis; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Erythromycin; Female; Fetal Membranes, Premature Rupture; Follow-Up Studies; Humans; Infant, Newborn; Pregnancy; Pregnancy Outcome; Reference Values; Risk Assessment; Treatment Outcome | 2002 |
MRC ORACLE Children Study. Long term outcomes following prescription of antibiotics to pregnant women with either spontaneous preterm labour or preterm rupture of the membranes.
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Child; Double-Blind Method; Drug Therapy, Combination; Erythromycin; Female; Fetal Membranes, Premature Rupture; Follow-Up Studies; Humans; Obstetric Labor, Premature; Outcome Assessment, Health Care; Pregnancy; Research Design; Surveys and Questionnaires; Treatment Outcome | 2008 |
Randomized trial of prophylactic antibiotic therapy after preterm amnion rupture.
Topics: Adult; Ampicillin; Bacterial Infections; Cesarean Section; Chorioamnionitis; Erythromycin; Female; Fetal Membranes, Premature Rupture; Follow-Up Studies; Gonorrhea; Humans; Infant, Newborn; Length of Stay; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Trimester, Second; Pregnancy Trimester, Third; Streptococcal Infections; Treatment Outcome | 1993 |
Antibiotic therapy for reduction of infant morbidity after preterm premature rupture of the membranes. A randomized controlled trial. National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network.
Topics: Adult; Amoxicillin; Ampicillin; Carrier State; Double-Blind Method; Drug Therapy, Combination; Erythromycin; Female; Fetal Membranes, Premature Rupture; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Pregnancy Trimester, Second; Pregnancy Trimester, Third; Proportional Hazards Models; Statistics, Nonparametric; Streptococcal Infections; Streptococcus agalactiae | 1997 |
Ureaplasma urealyticum, erythromycin and respiratory morbidity in high-risk preterm neonates.
Topics: Anti-Bacterial Agents; Erythromycin; Female; Fetal Membranes, Premature Rupture; Gestational Age; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Logistic Models; Male; Morbidity; Pregnancy; Respiration, Artificial; Respiratory Distress Syndrome, Newborn; Risk Factors; Ureaplasma Infections; Ureaplasma urealyticum | 1998 |
Broad-spectrum antibiotics for preterm, prelabour rupture of fetal membranes: the ORACLE I randomised trial. ORACLE Collaborative Group.
Topics: Adult; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Drug Therapy, Combination; Enterocolitis, Necrotizing; Erythromycin; Female; Fetal Membranes, Premature Rupture; Humans; Infant, Newborn; Obstetric Labor, Premature; Pregnancy; Pregnancy Outcome; Treatment Outcome | 2001 |
Erythromycin therapy in preterm premature rupture of the membranes: a prospective, randomized trial of 220 patients.
Topics: Delivery, Obstetric; Double-Blind Method; Erythromycin; Female; Fetal Membranes, Premature Rupture; Humans; Infection Control; Pregnancy; Pregnancy Outcome; Prospective Studies; Time Factors; Vaginal Smears | 1992 |
Antimicrobial therapy in preterm premature rupture of membranes: results of a prospective, double-blind, placebo-controlled trial of erythromycin.
Topics: Adolescent; Adult; Bacteria; Bacterial Infections; Double-Blind Method; Erythromycin; Female; Fetal Membranes, Premature Rupture; Humans; Infant, Newborn; Obstetric Labor, Premature; Pregnancy; Pregnancy Outcome; Prospective Studies; Puerperal Infection; Risk Factors | 1991 |
Cervicovaginal microflora and pregnancy outcome: results of a double-blind, placebo-controlled trial of erythromycin treatment.
Topics: Adolescent; Adult; Bacterial Infections; Cervix Uteri; Double-Blind Method; Erythromycin; Female; Fetal Membranes, Premature Rupture; Follow-Up Studies; Genital Diseases, Female; Humans; Multivariate Analysis; Obstetric Labor, Premature; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Prospective Studies; Regression Analysis; Risk Factors; Vagina | 1990 |
Erythromycin therapy for subclinical intrauterine infections in threatened preterm delivery--a preliminary report.
Topics: Erythromycin; Female; Fetal Membranes, Premature Rupture; Humans; Mycoplasmatales Infections; Obstetric Labor, Premature; Placebos; Pregnancy; Random Allocation; Time Factors; Tocolysis; Ureaplasma; Uterine Diseases | 1988 |
33 other study(ies) available for erythromycin and Fetal Membranes, Premature Rupture
Article | Year |
---|---|
Pathogens in preterm prelabour rupture of membranes and erythromycin for antibiotic prophylaxis: a retrospective analysis.
Topics: Adult; Anti-Bacterial Agents; Antibiotic Prophylaxis; Drug Resistance, Bacterial; Erythromycin; Female; Fetal Membranes, Premature Rupture; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Hong Kong; Humans; Infant, Newborn; Neonatal Sepsis; Pregnancy; Pregnancy Outcome; Retrospective Studies | 2019 |
Azithromycin in the Treatment of Preterm Prelabor Rupture of Membranes Demonstrates a Lower Risk of Chorioamnionitis and Postpartum Endometritis with an Equivalent Latency Period Compared with Erythromycin Antibiotic Regimens.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Antibiotic Prophylaxis; Azithromycin; Cesarean Section; Chorioamnionitis; Drug Administration Schedule; Endometritis; Erythromycin; Female; Fetal Membranes, Premature Rupture; Humans; Middle Aged; Neonatal Sepsis; Postpartum Period; Pregnancy; Prospective Studies; Young Adult | 2020 |
Erythromycin compared to amoxicillin and azithromycin for antimicrobial prophylaxis for preterm premature rupture of the membranes: a retrospective study.
Topics: Adult; Amoxicillin; Antibiotic Prophylaxis; Azithromycin; Delivery, Obstetric; Erythromycin; Female; Fetal Membranes, Premature Rupture; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Male; Pregnancy; Pregnancy Complications, Infectious; Retrospective Studies; Streptococcal Infections; Streptococcus agalactiae; Time Factors; Treatment Outcome | 2021 |
Comparison of Azithromycin versus Erythromycin for Prolongation of Latency in Pregnancies Complicated by Preterm Premature Rupture of Membranes.
Topics: Adult; Anti-Bacterial Agents; Azithromycin; Cost-Benefit Analysis; Erythromycin; Female; Fetal Membranes, Premature Rupture; Gestational Age; Humans; Infant, Newborn; Logistic Models; Multivariate Analysis; Obstetric Labor, Premature; Pregnancy; Pregnancy Outcome; Retrospective Studies; Treatment Outcome; Young Adult | 2017 |
Vaginal dysbiosis increases risk of preterm fetal membrane rupture, neonatal sepsis and is exacerbated by erythromycin.
Topics: Adult; Antibiotic Prophylaxis; Cohort Studies; Disease Progression; Dysbiosis; Erythromycin; Female; Fetal Membranes, Premature Rupture; Humans; Infant, Newborn; Microbiota; Neonatal Sepsis; Pregnancy; Premature Birth; Prenatal Care; Risk Factors; RNA, Bacterial; RNA, Ribosomal, 16S; Vagina | 2018 |
[Antibiotic prophylaxis in preterm premature rupture of membranes: CNGOF preterm premature rupture of membranes guidelines].
Topics: Amoxicillin; Antibiotic Prophylaxis; Cephalosporins; Erythromycin; Escherichia coli; Escherichia coli Infections; Female; Fetal Membranes, Premature Rupture; France; Humans; Infant, Newborn; Neonatal Sepsis; Pregnancy; Premature Birth; Streptococcal Infections; Streptococcus agalactiae | 2018 |
Azithromycin vs erythromycin for the management of preterm premature rupture of membranes.
Topics: Adult; Amoxicillin; Ampicillin; Anti-Bacterial Agents; Azithromycin; Chorioamnionitis; Cohort Studies; Dose-Response Relationship, Drug; Drug Administration Schedule; Erythromycin; Female; Fetal Membranes, Premature Rupture; Humans; Infant, Newborn; Intensive Care Units, Neonatal; Length of Stay; Pregnancy; Respiratory Distress Syndrome, Newborn; Retrospective Studies | 2019 |
Comparison of the effect of penicillins versus erythromycin in preventing neonatal group B streptococcus infection in active carriers following preterm prelabor rupture of membranes.
Topics: Adult; Anti-Bacterial Agents; Antibiotic Prophylaxis; Carrier State; Erythromycin; Female; Fetal Membranes, Premature Rupture; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Penicillins; Pregnancy; Streptococcal Infections; Streptococcus agalactiae | 2014 |
A retrospective comparison of antibiotic regimens for preterm premature rupture of membranes.
Topics: Adult; Ampicillin; Anti-Bacterial Agents; Azithromycin; Cohort Studies; Comparative Effectiveness Research; Delivery, Obstetric; Drug Monitoring; Drug Substitution; Drug Therapy, Combination; Erythromycin; Female; Fetal Membranes, Premature Rupture; Humans; Indiana; Infant, Newborn; Obstetric Labor Complications; Pregnancy; Retrospective Studies; Treatment Outcome | 2014 |
Maternal serum interleukin-6 in the management of patients with preterm premature rupture of membranes.
Topics: Adult; Amniotic Fluid; Analysis of Variance; Anti-Bacterial Agents; Anti-Inflammatory Agents; Birth Weight; C-Reactive Protein; Chorioamnionitis; Dexamethasone; Erythromycin; Female; Fetal Membranes, Premature Rupture; Gestational Age; Humans; Incidence; Infant, Newborn; Interleukin-6; Placenta; Pregnancy; Young Adult | 2016 |
Comparison of antibiotic regimens in preterm premature rupture of membranes: neonatal morbidity and 2-year follow-up of neurologic outcome.
Topics: Adult; Anti-Bacterial Agents; Cephalosporins; Clarithromycin; Drug Therapy, Combination; Erythromycin; Female; Fetal Membranes, Premature Rupture; Follow-Up Studies; Gestational Age; Humans; Infant; Infant Mortality; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Pregnancy; Pregnancy Outcome; Retrospective Studies; Time Factors | 2017 |
Childhood outcomes after prescription of antibiotics to pregnant women with preterm rupture of the membranes: 7-year follow-up of the ORACLE I trial.
Topics: Adult; Amoxicillin-Potassium Clavulanate Combination; Antibiotic Prophylaxis; Child; Child Mortality; Child Welfare; Educational Status; England; Erythromycin; Female; Fetal Membranes, Premature Rupture; Follow-Up Studies; Health Status; Humans; Logistic Models; Male; Pelvic Infection; Pregnancy; Pregnancy Complications, Infectious; Treatment Outcome | 2008 |
Antibiotics in preterm labour--the ORACLE speaks.
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Erythromycin; Female; Fetal Membranes, Premature Rupture; Humans; Obstetric Labor, Premature; Pregnancy; Prenatal Exposure Delayed Effects; Treatment Outcome | 2008 |
Has publication of the results of the ORACLE Children Study changed practice in the UK?
Topics: Anti-Bacterial Agents; Erythromycin; Female; Fetal Membranes, Premature Rupture; Follow-Up Studies; Hospitals, Maternity; Humans; Obstetric Labor, Premature; Obstetrics; Pregnancy; Professional Practice; Randomized Controlled Trials as Topic; Surveys and Questionnaires; United Kingdom | 2010 |
Providing the results of research to participants: a mixed-method study of the benefits and challenges of a consultative approach.
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Disclosure; Erythromycin; Feedback; Female; Fetal Membranes, Premature Rupture; Focus Groups; Humans; Pregnancy; Pregnancy Complications; Referral and Consultation; Research Subjects; Surveys and Questionnaires; Treatment Outcome | 2011 |
The antibiotic treatment of PPROM study: systemic maternal and fetal markers and perinatal outcomes.
Topics: Adult; Amoxicillin; Ampicillin; Anti-Bacterial Agents; Cytokines; Erythromycin; Female; Fetal Blood; Fetal Membranes, Premature Rupture; Humans; Infant, Newborn; Intercellular Adhesion Molecule-1; Pregnancy; Pregnancy Outcome; Randomized Controlled Trials as Topic | 2012 |
Characteristics of children with cerebral palsy in the ORACLE children study.
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Birth Weight; Cerebral Palsy; Child; Educational Status; Erythromycin; Female; Fetal Membranes, Premature Rupture; Gestational Age; Humans; Male; Morbidity; Mothers; Movement Disorders; Multiple Birth Offspring; Obstetric Labor, Premature; Poverty; Pregnancy; Premature Birth; Severity of Illness Index | 2012 |
The effect of the publication of a major clinical trial in a high impact journal on clinical practise: the ORACLE Trial experience.
Topics: Amoxicillin-Potassium Clavulanate Combination; Drug Therapy, Combination; Erythromycin; Female; Fetal Membranes, Premature Rupture; Hospitals, Maternity; Humans; Maternal Health Services; Obstetric Labor, Premature; Practice Patterns, Physicians'; Pregnancy; Prenatal Care; Publishing; Randomized Controlled Trials as Topic; Surveys and Questionnaires; United Kingdom | 2002 |
Effect of treatment for Chlamydia trachomatis during pregnancy.
Topics: Adult; Chlamydia Infections; Chlamydia trachomatis; Erythromycin; Female; Fetal Membranes, Premature Rupture; Humans; Infant, Low Birth Weight; Infant, Newborn; Obstetric Labor, Premature; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome | 2003 |
Hazards of widespread use of erythromycin for preterm prelabour rupture of membranes.
Topics: Anti-Bacterial Agents; Drug Resistance, Microbial; Drug Utilization Review; Erythromycin; Female; Fetal Membranes, Premature Rupture; Guideline Adherence; Health Services Misuse; Humans; Hypersensitivity; Infant, Newborn; Practice Guidelines as Topic; Practice Patterns, Physicians'; Pregnancy; Risk Factors; United Kingdom | 2003 |
Pseudomembranous colitis, a complication of erythromycin and preterm prelabour rupture of membranes.
Topics: Adult; Anti-Bacterial Agents; Enterocolitis, Pseudomembranous; Erythromycin; Female; Fetal Membranes, Premature Rupture; Humans; Pregnancy | 2006 |
A retrospective review of ampicillin-sulbactam and amoxicillin + clavulanate vs cefazolin/cephalexin and erythromycin in the setting of preterm premature rupture of membranes: maternal and neonatal outcomes.
Topics: Adult; Ampicillin; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cefazolin; Cephalexin; Chorioamnionitis; Clavulanic Acid; Drug Therapy, Combination; Endometritis; Enterocolitis, Necrotizing; Erythromycin; Female; Fetal Membranes, Premature Rupture; Humans; Pregnancy; Pregnancy Outcome; Retrospective Studies; Sulbactam | 2008 |
Expectant management of premature rupture of membranes with amniotic fluid cultures positive for Ureaplasma urealyticum alone.
Topics: Amniotic Fluid; Erythromycin; Female; Fetal Membranes, Premature Rupture; Humans; Obstetric Labor, Premature; Pregnancy; Pregnancy Complications, Infectious; Prenatal Care; Ureaplasma Infections; Ureaplasma urealyticum | 1994 |
[Incidence of inflammatory placental changes in threatened premature labor with and without additional antibiotic therapy].
Topics: Administration, Intravaginal; Ampicillin; Antibiotic Prophylaxis; Cefotiam; Chorioamnionitis; Dose-Response Relationship, Drug; Drug Administration Schedule; Erythromycin; Female; Fenoterol; Fetal Membranes, Premature Rupture; Humans; Infant, Newborn; Inflammation; Infusions, Intravenous; Obstetric Labor, Premature; Placenta; Placenta Diseases; Povidone-Iodine; Pregnancy; Tocolysis; Tocolytic Agents | 1997 |
Antibiotic treatment in preterm PROM.
Topics: Amoxicillin; Ampicillin; Anti-Bacterial Agents; Double-Blind Method; Erythromycin; Female; Fetal Membranes, Premature Rupture; Humans; Penicillins; Pregnancy; Pregnancy Outcome; Randomized Controlled Trials as Topic; Reproducibility of Results | 1998 |
Successful outcome after antibiotic treatment of postamniocentesis membrane rupture and chorioamnionitis in multiple pregnancy.
Topics: Adult; Amniocentesis; Ampicillin; Anti-Inflammatory Agents; Betamethasone; Chorioamnionitis; Clindamycin; Drug Administration Schedule; Drug Therapy, Combination; Erythromycin; Female; Fetal Death; Fetal Membranes, Premature Rupture; Gentamicins; Humans; Infant, Newborn; Injections, Intravenous; Male; Oligohydramnios; Pregnancy; Pregnancy Outcome; Pregnancy Trimester, Second; Triplets | 1999 |
Effect of antibiotic therapy in preterm premature rupture of the membranes on neonatal mortality and morbidity.
Topics: Adult; Ampicillin; Antibiotic Prophylaxis; Bacterial Infections; Delivery, Obstetric; Drug Therapy, Combination; Erythromycin; Female; Fetal Membranes, Premature Rupture; Humans; Infant Mortality; Infant, Newborn; Infant, Newborn, Diseases; Pregnancy; Retrospective Studies | 2000 |
Do antibiotics improve neonatal outcomes in preterm premature rupture of membranes (PPROM)?
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Double-Blind Method; Drug Therapy, Combination; Erythromycin; Female; Fetal Membranes, Premature Rupture; Humans; Infant, Newborn; Infant, Premature, Diseases; Multicenter Studies as Topic; Obstetric Labor, Premature; Pregnancy; Randomized Controlled Trials as Topic | 2001 |
Broad-spectrum antibiotics in ORACLE.
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Drug Therapy, Combination; Erythromycin; Female; Fetal Membranes, Premature Rupture; Humans; Pregnancy | 2001 |
Direct inhibition of proteases and cervical plasminogen activator by antibiotics.
Topics: Ampicillin; Anti-Bacterial Agents; Cervix Uteri; Cloxacillin; Endopeptidases; Erythromycin; Female; Fetal Membranes, Premature Rupture; Humans; Penicillin G; Plasminogen Activators; Plasminogen Inactivators; Pregnancy; Protease Inhibitors | 1992 |
Eradication of Ureaplasma urealyticum from the amniotic fluid with transplacental antibiotic treatment.
Topics: Adult; Amniotic Fluid; Ampicillin; Chorioamnionitis; Clindamycin; Drug Therapy, Combination; Erythromycin; Female; Fetal Membranes, Premature Rupture; Gentamicins; Humans; Injections, Intravenous; Pregnancy; Ureaplasma Infections; Ureaplasma urealyticum | 1992 |
Antibiotic inhibition of bacterially induced fetal membrane weakening.
Topics: Clindamycin; Endopeptidases; Erythromycin; Extraembryonic Membranes; Female; Fetal Membranes, Premature Rupture; Humans; In Vitro Techniques; Pregnancy; Staphylococcus aureus | 1990 |
Preterm premature rupture of the membranes: neonatal outcome in 215 cases of an active conservative management.
Topics: Ampicillin; Betamethasone; Erythromycin; Female; Fetal Membranes, Premature Rupture; Humans; Pregnancy; Pregnancy Outcome; Ritodrine | 1989 |